Inventor profile of:

Charles A. Gersbach

City:

Durham, North Carolina

Country:

United States

Published Applications:

24

Last publication date:

2025-05-15

Top Assignees for applications by Charles A. Gersbach

The entities that hold a legal rights for patent applications filed by inventor Gersbach Charles A.:

Recent patent applications by Gersbach Charles A.

Charles A. Gersbach from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-15
US20250154503A1
Chemistry; metallurgy

COMPOSITIONS, SYSTEMS, AND METHODS FOR PROGRAMMING T CELL PHENOTYPES THROUGH TARGETED GENE REPRESSION

#2 | 2025-05-01
US20250134999A1
Human necessities

COMPOSITIONS, SYSTEMS, AND METHODS FOR PROGRAMMING T CELL PHENOTYPES THROUGH TARGETED GENE ACTIVATION

#3 | 2024-10-10
US20240336892A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE INDUCTION AND TUNING OF GENE EXPRESSION

#4 | 2024-08-01
US20240254483A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF FRATAXIN (FXN)

#5 | 2024-08-01
US20240252684A1
Human necessities

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF METHYL-CPG BINDING PROTEIN 2 (MECP2)

#6 | 2022-10-06
US20220315946A1
Chemistry; metallurgy

COMPOSITIONS, SYSTEMS AND METHODS FOR CELL THERAPY

#7 | 2021-02-04
US20210032654A1
Chemistry; metallurgy

RNA-GUIDED GENE EDITING AND GENE REGULATION

#8 | 2021-01-07
US20210002665A1
Chemistry; metallurgy

RNA-GUIDED GENE EDITING AND GENE REGULATION

#9 | 2020-12-10
US20200385695A1
Chemistry; metallurgy

Compositions and methods for epigenome editing

#10 | 2020-11-05
US20200347105A1
Chemistry; metallurgy

GENOME ENGINEERING WITH CRISPR-CAS SYSTEMS IN EUKARYOTES

#11 | 2020-10-08
US20200318139A1
Chemistry; metallurgy

Genome engineering with type I CRISPR systems in eukaryotic cells

#12 | 2019-06-27
US20190194633A1
Chemistry; metallurgy

COMPOSITIONS, SYSTEMS AND METHODS FOR PROGRAMMING IMMUNE CELL FUNCTION THROUGH TARGETED GENE REGULATION

#13 | 2019-05-23
US20190151476A1
Human necessities

Therapeutic applications of CPF1-based genome editing

#14 | 2019-05-09
US20190136229A1
Chemistry; metallurgy

Compositions and methods of improving specificity in genomic engineering using RNA-guided endonucleases

#15 | 2019-05-09
US20190134221A1
Human necessities

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING DUCHENNE MUSCULAR DYSTROPHY

#16 | 2019-05-02
US20190127713A1
Chemistry; metallurgy

CRISPR/CAS9-BASED REPRESSORS FOR SILENCING GENE TARGETS IN VIVO AND METHODS OF USE

#17 | 2018-12-13
US20180353615A1
Human necessities

Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use

#18 | 2018-11-22
US20180334688A1
Chemistry; metallurgy

Genome engineering with Type I CRISPR systems in eukaryotic cells

#19 | 2018-11-08
US20180320197A1
Chemistry; metallurgy

RNA-guided gene editing and gene regulation

#20 | 2018-10-11
US20180291370A1
Chemistry; metallurgy

High-throughput screening of regulatory element function with epigenome editing technologies

#21 | 2018-07-19
US20180201951A1
Chemistry; metallurgy

Compositions, systems and methods for cell therapy

#22 | 2018-04-05
US20180094238A1
Chemistry; metallurgy

Compositions and methods for the induction and tuning of gene expression

#23 | 2018-01-25
US20180023064A1
Chemistry; metallurgy

Compositions and methods for epigenome editing

#24 | 2016-07-14
US20160201089A1
Chemistry; metallurgy

RNA-guided gene editing and gene regulation

InventorID:

1591035 ⎘